XML 102 R47.htm IDEA: XBRL DOCUMENT v3.25.1
Note H - Stockholders' Equity (Details Textual) - USD ($)
12 Months Ended
Jan. 12, 2024
Dec. 10, 2023
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Accrued Liabilities to Noncontrolling Interests     $ 0 $ 214,000  
Repurchase of Noncontrolling Interest       (214,000)  
Stock Issued During Period Shares, Warrants Exercised (in shares)     103,500    
Class of Warrant or Right, Exercised During Period, Exercise Price (in dollars per share)     $ 0.5    
Proceeds from Warrant Exercises     $ 51,751 $ 0  
Deferred Compensation Arrangement with Individual, Shares Authorized for Issuance (in shares)     3,393,017 3,098,917 2,440,673
Chief Executive Officer, Chief Financial Officer and Employees [Member]          
Deferred Compensation Arrangement with Individual, Shares Authorized for Issuance (in shares)     2,761,225 2,571,292  
Non-Employees [Member]          
Common Stock, Capital Shares Reserved for Future Issuance (in shares)     631,792 527,625  
Additional Paid-in Capital [Member]          
Repurchase of Noncontrolling Interest       $ (485,119)  
Milestone Medical Inc. [Member]          
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable   $ 205,000      
Accrued Liabilities to Noncontrolling Interests       214,000  
Milestone Medical Inc. [Member] | Additional Paid-in Capital [Member]          
Repurchase of Noncontrolling Interest       $ 485,000  
Public Offering [Member]          
Stock Issued During Period, Shares, New Issues (in shares)   4,765,000      
Shares Issued, Price Per Share (in dollars per share)   $ 0.63      
Proceeds from Issuance of Common Stock   $ 2.6      
Over-Allotment Option [Member]          
Stock Issued During Period, Shares, New Issues (in shares) 372,110 714,750      
Proceeds from Issuance of Common Stock $ 192,156